Alert icon You’ve been geo-located to Saskatchewan. Please ensure this is representative of where your farm resides. If not, please select the correct province. Sorry we cannot determine your location. To accurately serve you better, please choose your province below. Close icon
Region: Arrow down icon

Select your province to ensure relevant content

Select your preferred language.

Choisissez votre langue préférée

June 13, 2023

Bayer launches Varro FX delivering cross-spectrum control of the toughest weeds like wild oats

Unique new herbicide formulation is the first Group 2 emulsifiable concentrate on the market in Western Canada

Calgary, AB (June 9, 2023) – Today the Crop Science division of Bayer announced that Varro® FX cross-spectrum herbicide has been registered for use in Western Canada on spring and winter wheat. As the first Group 2 emulsifiable concentrate (EC) on the market in Western Canada, Varro FX provides advanced control of the toughest grass weeds, including Group 1-resistant wild oats and broadleaf weeds like cleavers, kochia, wild buckwheat and more. With a wide application window, and cross-spectrum targeting, Varro FX is an easy-to-use formulation offering flexibility.

“With the EC formulation of Varro FX, farmers will experience improved handling, mixing and an easier tank and boom cleanout while boosting agronomic performance,” says Ashley Smith, Marketing Manager, Crop Protection West at Bayer. “Flexible re-cropping, including in the brown soil zone, gives farmers the freedom to effectively tackle tough to control weeds with ease.”

Varro FX combines the trusted power of Group 2 thiencarbazone-methyl with the addition of Group 4 fluroxypyr to offer cross-spectrum control of tough grass weeds. It can be tank mixed with a wide range of cereal broadleaf herbicides such as Buctril® M, Thumper®, Infinity®, MCPA Ester and 2,4-D Ester herbicides for complete control of many grass and broadleaf weeds. Varro FX requires no external surfactant (NIS or AMS), and its unique Group 2 EC formulation means it is easier to mix and handle and provides enhanced coverage for more consistent grass weed control.

“To empower farmers to get back to doing the things they love, Bayer is consistently striving for solutions to boost ease of use while enhancing performance – Varro FX embodies this vision,” says Smith.

Varro FX will be available in 8.1 L jugs and 129.6 L drums for the 2024 growing season. Farmers are encouraged to talk to their local Bayer representative and retail to learn more, or visit cropscience.bayer.ca/products/herbicides/varro-fx

ALWAYS READ AND FOLLOW PESTICIDE LABEL DIRECTIONS. Bayer, Bayer Cross, , Buctril®, Infinity®, Thumper®, and Varro® are trademarks of Bayer Group. Used under license. All other trademarks are the property of their respective owners. Bayer CropScience Inc. is a member of CropLife Canada. ©2023 Bayer Group. All rights reserved.

 

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2022, the Group employed around 101,000 people and had sales of 50.7 billion euros. R&D expenses before special items amounted to 6.2 billion euros. For more information, go to www.bayer.ca.

 

For further information, contact:

Ashley Smith
Marketing Manager, Crop Protection West
Bayer CropScience Inc.
Phone: +1 587 434-9650
Ashley.smith2@bayer.com

Adam Bornstein
Senior Account Manager
Weber Shandwick Canada
Phone: + 1 905 505-2540
abornstein@webershandwick.com

 

Forward-Looking Statements

This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.